Current through Register Vol. 24-18, September 15, 2024
(1) The
following definitions apply to this section, unless the context clearly
indicates otherwise:
(a) "Cartoon" means any
drawing or other depiction of an object, person, animal, creature, or any
similar caricature that meets any of the following criteria:
(i) The use of comically exaggerated
features;
(ii) The attribution of
human characteristics to animals, plants, or other objects;
(iii) The attribution of animal, plant, or
other object characteristics to humans;
(iv) The attribution of unnatural or
extra-human abilities.
(b) "Child resistant packaging" means
packaging that is used to reduce the risk of poisoning in persons under the age
of 21 through the ingestion of potentially hazardous items including, but not
limited to, cannabis concentrates, useable cannabis, and cannabis-infused
products.
(c) "Especially appealing
to persons under the age of 21" means a product or label that includes, but is
not limited to:
(i) The use of
cartoons;
(ii) Bubble-type or other
cartoon-like font;
(iii) A design,
brand, or name that resembles a noncannabis consumer product that is marketed
to persons under the age of 21;
(iv) Symbols or celebrities that are commonly
used to market products to persons under the age of 21;
(v) Images of persons under the age of 21;
or
(vi) Similarities to products or
words that refer to products that are commonly associated or marketed to
persons under the age of 21.
(d) "Cannabis concentrates" means products
consisting wholly or in part of the resin extracted from any part of the plant
Cannabis and having a THC concentration greater than 10
percent, consistent with
RCW
69.50.101(z).
(e) "Cannabis edible" means a
cannabis-infused product as defined in
RCW
69.50.101(ff).
(f) "Cannabis topical" or "topical" means any
product containing parts of the cannabis plant that is intended for application
to the body's surface including, but not limited to, lotions, ointments,
salves, gels, or cream that are not intended for ingestion, inhalation, or
insertion by humans or animals.
(g)
"Structure and function claims" mean a description of the role of a cannabis
product intended to affect normal structure and function in humans,
characterized by the means by which a cannabis product acts to maintain such
structure or function, or describe the general well-being from consumption of a
cannabis product, consistent with the guidance provided in
21 U.S.C. Sec.
343(6).
(h) "Useable cannabis" means dried cannabis
flowers consistent with
RCW
69.50.101(ww). The term
"useable cannabis" does not include either cannabis-infused products or
cannabis concentrates.
(2)
Cannabis concentrates. The
following standards apply to all packaging and labeling of cannabis
concentrates:
(a) Containers or packaging
containing cannabis concentrates must protect the product from contamination.
Containers or packaging must not impart any toxic or harmful substance to the
cannabis concentrate.
(b) Cannabis
concentrates must be packaged:
(i) In child
resistant packaging consistent with 16 C.F.R. Part 1700 , Poison Prevention
Packaging Act; or
(ii) In plastic
that is two mil or greater in thickness, heat sealed without an easy-open tab,
dimple, corner, or flap that will protect persons under the age of 21 from
accidental exposure to cannabis concentrates.
(c) Cannabis concentrates must not be labeled
as organic unless permitted by the U.S. Department of Agriculture consistent
with the Organic Foods Production Act.
(d) Cannabis concentrate labels must comply
with the version of NIST Handbook 130, Uniform Packaging and Labeling
regulation adopted in chapter 16-662 WAC.
(e) Cannabis concentrate labels must clearly
and visibly provide all of the following information:
(i) The business or trade name and the nine
digit Washington state unified business identifier (UBI) number of the cannabis
producer and processor;
(ii) The
lot number of the product (the unique identifier number generated by the
board's traceability system). This must be the same number that appears on the
transport manifest;
(iii) The net
weight in ounces and grams or volume as applicable;
(iv) Total THC (delta-9-tetrahydrocannabinol)
meaning the concentration of THC and THCA, total CBD (cannabidiol) meaning the
concentration of CBDA and CBD, using the formulas referenced in WAC
314-55-102;
(v) Medically and scientifically accurate and
reliable information about the health and safety risks posed by cannabis
use;
(vi) If solvents were used to
create concentrate or extract, a statement that discloses the type of
extraction method, including in solvents or gases used to create the
concentrate; and
(vii) A complete
list of any other chemicals, compounds, additives, thickening agents, terpenes,
or other substances used to produce or added to the concentrate or extract at
any point during production. A copy of the complete list of chemicals,
compounds, additives, thickening agents, terpenes, or other substances must be
kept and maintained at the facility in which the cannabis concentrates are
processed.
(f) Cannabis
concentrate labels may not contain any statement, depiction, or illustration
that:
(i) Is false or misleading, consistent
with guidance provided in
21 C.F.R. Sec.
101.18(a);
(ii) Promotes over consumption;
(iii) Represents that the use of cannabis has
curative or therapeutic effects;
(iv) Depicts a person under the age of 21
consuming cannabis; or
(v) Is
especially appealing to persons under 21 years of age as defined in subsection
(1)(c) of this section.
(g) The following statements must be included
on all cannabis concentrate labels:
(i)
"Warning - May be habit forming;"
(ii) "Unlawful outside Washington
State;"
(iii) "It is illegal to
operate a motor vehicle while under the influence of cannabis;"
(iv) The cannabis universal symbol as
provided in WAC
314-55-106;
and
(v) "Smoking is hazardous to
your health."
(h)
Product labeling for cannabis concentrates identified as compliant cannabis
product under
RCW
69.50.375(4) and chapter
246-70 WAC may include:
(i) A structure or
function claim describing the intended role of the product to maintain the
structure or any function of the body; or
(ii) Characterization of the documented
mechanism by which the product acts to maintain such structure or function,
provided that the claim is truthful and not misleading.
(iii) Any statement made under this
subsection may not claim to diagnose, mitigate, treat, cure, or prevent any
disease.
(i) Where there
is one statement made under (h) of this subsection, or there is a warning
describing the psychoactive effects of the cannabis product that is not false
or misleading, the disclaimer must state, "This statement has not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(j) Where there is more than one statement
made under (h) of this subsection, or there is a warning describing the
psychoactive effects of the cannabis product that is not false or misleading,
the disclaimer must state, "These statements have not been evaluated by the
State of Washington. This product is not intended to diagnose, treat, cure, or
prevent any disease."
(3)
Cannabis edibles in solid
form. The following standards apply to all packaging and labeling of
canna-bis edibles in solid form:
(a)
Containers or packaging containing cannabis edibles in solid form must protect
the product from contamination. Containers or packaging must not impart any
toxic or harmful substance to the cannabis edibles in solid form.
(b) Cannabis edibles in solid form must be
packaged:
(i) In child resistant packaging
consistent with 16 C.F.R. Part 1700 , Poison Prevention Packaging Act;
or
(ii) In plastic that is two mil
or greater in thickness, heat sealed without an easy-open tab, dimple, corner,
or flap that will protect persons under the age of 21 from accidental exposure
to cannabis edibles in solid form.
(c) Cannabis-infused edibles in solid form,
such as capsules, lozenges, and similar products approved by the board on a
case-by-case basis may be packaged loosely within a resealing outer package
that is child resistant in accordance with Title 16 C.F.R. 1700 of the Poison
Prevention Packaging Act.
(d)
Cannabis edibles in solid form must not be labeled as organic unless permitted
by the U.S. Department of Agriculture consistent with the Organic Foods
Production Act.
(e) Labels for
cannabis edibles in solid form must comply with the version of NIST Handbook
130, Uniform Packaging and Labeling regulation adopted in chapter 16-662
WAC.
(f) Labels for cannabis
edibles in solid form must clearly and visibly provide all of the following
information:
(i) The business or trade name
and the nine digit Washington state unified business identifier (UBI) number of
the licensees that produced and processed the cannabis or cannabis
products;
(ii) The lot number of
the product (the unique identifier number generated by the board's traceability
system). This must be the same number that appears on the transport
manifest;
(iii) The serving size
and the number of servings contained within the unit. If more than one serving
is in a package, the label must prominently display the serving size, the
number of servings in the package and the amount of product per
serving;
(iv) Net weight in ounces
and grams or volume as applicable;
(v) Total THC (delta-9-tetrahydrocannabinol)
meaning the concentration of THC and THCA, total CBD (cannabidiol) meaning the
concentration of CBDA and CBD, using the formulas referenced in WAC
314-55-102;
(vi) Medically and scientifically accurate
and reliable information about the health and safety risks posed by cannabis
use;
(vii) A list of ingredients in
descending order of predominance by weight or volume as applicable and a list
of major food allergens as defined in the Food Allergen Labeling and Consumer
Protection Act of 2004;
(viii) If
solvents were used, a statement that discloses the type of extraction method,
including any solvents, gases, or other chemicals or compounds used to produce
or that were added to the extract.
(g) Labels for cannabis edibles in solid form
may not contain any statement, depiction, or illustration that:
(i) Is false or misleading, consistent with
guidance provided in
21 C.F.R. Sec.
101.18(a);
(ii) Promotes over consumption;
(iii) Represents that the use of cannabis has
curative or therapeutic effects;
(iv) Depicts a person under the age of 21
consuming cannabis, or is especially appealing to persons under 21 years of age
as defined in subsection (1)(c) of this section.
(h) The following warning statements must be
included on all labels for all cannabis edibles in solid form. The following
warning statements must be legible, unobscured, and visible to the consumer:
(i) "Warning - May be habit
forming;"
(ii) "Unlawful outside
Washington State;"
(iii) "It is
illegal to operate a motor vehicle under the influence of cannabis;"
(iv) The cannabis universal symbol as
provided in WAC
314-55-106;
and
(v) "Caution: Intoxicating
effects may be delayed by 2+ hours."
(i) Product labeling for cannabis edibles in
solid form identified as compliant cannabis product under
RCW
69.50.375(4) and chapter
246-70 WAC may include:
(i) A structure or
function claim describing the intended role of the product to maintain the
structure or any function of the body; or
(ii) Characterization of the documented
mechanism by which the product acts to maintain such structure or function,
provided that the claim is truthful and not misleading.
(iii) Any statement made under this
subsection may not claim to diagnose, mitigate, treat, cure, or prevent any
disease.
(j) Where there
is one statement made under (i) of this subsection, or there is a warning
describing the psychoactive effects of the cannabis product, provided it is not
false or misleading, the disclaimer must state, "This statement has not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(k) Where there is more than one statement
made under (h) of this subsection, or there is a warning describing the
psychoactive effects of the cannabis product, provided they are not false or
misleading, the disclaimer must state, "These statements have not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(4)
Cannabis edibles in liquid
form. The following standards apply to all packaging and labeling of
canna-bis edibles in liquid form:
(a)
Containers or packaging containing cannabis edibles in liquid form must protect
the product from contamination. Containers or packaging must not impart any
toxic or harmful substance to the cannabis edibles in liquid form.
(b) Cannabis edibles in liquid form must be
packaged:
(i) In child resistant packaging
consistent with 16 C.F.R. Part 1700 , Poison Prevention Packaging Act;
or
(ii) In plastic that is two mil
or greater in thickness, heat sealed without an easy-open tab, dimple, corner,
or flap that will protect persons under the age of 21 from accidental exposure
to cannabis edibles in liquid form.
(iii) Cannabis edibles in liquid form that
include more than one serving must be packaged with a resealable closure or
cap. Cannabis edibles in liquid form must include a measuring device such as a
measuring cup or dropper. Hash marks on the bottle or package qualify as a
measuring device.
(c)
Cannabis edibles in liquid form must not be labeled as organic unless permitted
by the U.S. Department of Agriculture consistent with the Organic Foods
Production Act.
(d) Labels for
cannabis edibles in liquid form must comply with the version of NIST Handbook
130, Uniform Packaging and Labeling regulation adopted in chapter 16-662
WAC.
(e) Labels for cannabis
edibles in liquid form must clearly and visibly provide all of the following
information:
(i) The business or trade name
and the nine digit Washington state unified business identifier (UBI) number of
the licensees that produced and processed the cannabis or cannabis
products;
(ii) The lot number of
the product (the unique identifier number generated by the board's traceability
system). This must be the same number that appears on the transport
manifest;
(iii) The serving size
and the number of servings contained within the unit. If more than one serving
is in a package, the label must prominently display the serving size, the
number of servings in the package and the amount of product per
serving;
(iv) Net weight in ounces
and grams or volume as applicable;
(v) Total THC (delta-9-tetrahydrocannabinol)
meaning the concentration of THC and THCA, total CBD (cannabidiol) meaning the
concentration of CBDA and CBD, using the formulas referenced in WAC
314-55-102;
(vi) Medically and scientifically accurate
and reliable information about the health and safety risks posed by cannabis
use;
(vii) A list of all
ingredients in descending order of predominance by weight or volume as
applicable and a list of major food allergens as defined in the Food Allergen
Labeling and Protections Act of 2004;
(viii) If solvents were used, a statement
that discloses the type of extraction method, including any solvents, gases, or
other chemicals or compounds used to produce or added to the extract.
(f) Labels for cannabis edibles in
liquid form may not contain any statement, depiction, or illustration that:
(i) Is false or misleading, consistent with
guidance provided in
21 C.F.R. Sec.
101.18(a);
(ii) Promotes over consumption;
(iii) Represents the use of cannabis has
curative or therapeutic effects;
(iv) Depicts a person under the age of 21
consuming cannabis, or is especially appealing to persons under 21 years of age
as defined in subsection (1)(c) of this section.
(g) The following warning statements must be
included on all labels for all cannabis edibles in liquid form. The following
warning statements must be legible, unobscured, and visible to the consumer:
(i) "Warning - May be habit
forming;"
(ii) "Unlawful outside
Washington State;"
(iii) "It is
illegal to operate a motor vehicle under the influence of cannabis;"
(iv) The cannabis universal symbol as
provided in WAC
314-55-106;
and
(v) "Caution: Intoxicating
effects may be delayed by 2+ hours."
(h) Product labeling for cannabis edibles in
liquid form identified as compliant cannabis product under
RCW
69.50.375(4) and chapter
246-70 WAC may include:
(i) A structure or
function claim describing the intended role of the product to maintain the
structure or any function of the body; or
(ii) Characterization of the documented
mechanism by which the product acts to maintain such structure or function,
provided that the claim is truthful and not misleading.
(iii) Any statement made under this
subsection may not claim to diagnose, mitigate, treat, cure, or prevent any
disease.
(i) Where there
is one statement made under (h) of this subsection, or there is a warning
describing the psychoactive effects of the cannabis product, provided it is not
false or misleading, the disclaimer must state, "This statement has not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(j) Where there is more than one statement
made under (h) of this subsection, or there is a warning describing the
psychoactive effects of the cannabis product, provided they are not false or
misleading, the disclaimer must state, "These statements have not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(5)
Useable cannabis. The
following standards apply to all packaging and labeling of useable cannabis:
(a) Containers or packaging containing
useable cannabis must protect the product from contamination. Containers or
packaging must not impart any toxic or harmful substance to the useable
cannabis.
(b) Useable cannabis must
not be labeled as organic unless permitted by the U.S. Department of
Agriculture consistent with the Organic Foods Production Act.
(c) Useable cannabis must comply with the
version of NIST Handbook 130, Uniform Packaging and Labeling regulation adopted
in chapter 16-662 WAC.
(d) Labels
for useable cannabis must clearly and visibly provide all of the following
information:
(i) The business or trade name
and the nine digit Washington state unified business identifier (UBI) number of
the licensees that produced and processed the cannabis or cannabis
products;
(ii) The lot number of
the product (the unique identifier number generated by the board's traceability
system). This must be the same number that appears on the transport
manifest;
(iii) Net weight in
ounces and grams or volume as applicable;
(iv) Total THC (delta-9-tetrahydrocannabinol)
meaning the concentration of THC and THCA, total CBD (cannabidiol) meaning the
concentration of CBDA and CBD, using the formulas referenced in WAC
314-55-102;
(v) Medically and scientifically accurate and
reliable information about the health and safety risks posed by cannabis
use.
(e) Labels for
useable cannabis may not contain any statement, depiction, or illustration
that:
(i) Is false or misleading, consistent
with guidance provided in
21 C.F.R. Sec.
101.18(a);
(ii) Promotes over consumption;
(iii) Represents the use of cannabis has
curative or therapeutic effects;
(iv) Depicts a person under the age of 21
consuming cannabis, or is especially appealing to persons under 21 years of age
as defined in subsection (1)(c) of this section.
(f) The following warning statements must be
included on all labels for all useable cannabis. The following warning
statements must be legible, unobscured, and visible to the consumer:
(i) "Warning - May be habit
forming;"
(ii) "Unlawful outside
Washington State;"
(iii) "It is
illegal to operate a motor vehicle under the influence of cannabis;"
(iv) The cannabis universal symbol as
provided in WAC
314-55-106;
and
(v) "Smoking is hazardous to
your health."
(g)
Product labeling for useable cannabis identified as compliant cannabis product
under
RCW
69.50.375(4) and chapter
246-70 WAC may include:
(i) A structure or
function claim describing the intended role of the product to maintain the
structure or any function of the body; or
(ii) Characterization of the documented
mechanism by which the product acts to maintain such structure or function,
provided that the claim is truthful and not misleading.
(iii) Any statement made under this
subsection may not claim to diagnose, mitigate, treat, cure, or prevent any
disease.
(h) Where there
is one statement made under (g) of this subsection, or there is a warning
describing the psychoactive effects of the cannabis product, provided it is not
false or misleading, the disclaimer must state, "This statement has not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(i) Where there is more than one statement
made under (g) of this subsection, or there is a warning describing the
psychoactive effects of the cannabis product, provided they are not false or
misleading, the disclaimer must state, "These statements have not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(6)
Cannabis mix. Cannabis mix
is defined in WAC
314-55-010(22)
as an intermediate lot that contains multiple strains of useable cannabis and
is chopped or ground so no particles are greater than 3 mm. The following
standards apply to all packaging and labeling of cannabis mix:
(a) Containers or packaging containing
cannabis mix must protect the product from contamination. Containers or
packaging must not impart any toxic or harmful substance to the cannabis
mix.
(b) Cannabis mix must not be
labeled as organic unless permitted by the U.S. Department of Agriculture
consistent with the Organic Foods Production Act.
(c) Cannabis mix must comply with the version
of NIST Handbook 130, Uniform Packaging and Labeling regulation adopted in
chapter 16-662 WAC.
(d) Labels for
cannabis mix must clearly and visibly provide all of the following information:
(i) The business or trade name and the nine
digit Washington state unified business identifier (UBI) number of the
licensees that produced and processed the cannabis or cannabis
products;
(ii) The lot number of
the product (the unique identifier number generated by the board's traceability
system). This must be the same number that appears on the transport
manifest;
(iii) Net weight in
ounces and grams or volume as applicable;
(iv) Total THC (delta-9-tetrahydrocannabinol)
meaning the concentration of THC and THCA, total CBD (cannabidiol) meaning the
concentration of CBDA and CBD, using the formulas referenced in WAC
314-55-102;
(v) Medically and scientifically accurate and
reliable information about the health and safety risks posed by cannabis
use;
(vi) If solvents were used, a
statement that discloses the type of extraction method, including any solvents,
gases, or other chemicals or compounds used to produce or added to the
extract;
(vii) Any other chemicals
or compounds used to produce or were added to the concentrate or
extract.
(e) Labels for
cannabis mix form may not contain any statement, depiction, or illustration
that:
(i) Is false or misleading, consistent
with guidance provided in
21 C.F.R. Sec.
101.18(a);
(ii) Promotes over consumption;
(iii) Represents the use of cannabis has
curative or therapeutic effects;
(iv) Depicts a person under the age of 21
consuming cannabis, or is especially appealing to persons under 21 years of age
as defined in subsection (1)(c) of this section.
(f) The following warning statements must be
included on all labels for all cannabis mix. The following warning statements
must legible, unobscured, and visible to the consumer:
(i) "Warning - May be habit forming;" (ii)
"Unlawful outside Washington State;"
(iii) "It is illegal to operate a motor
vehicle under the influence of cannabis;"
(iv) The cannabis universal symbol as
provided in WAC
314-55-106;
and
(v) "Smoking is hazardous to
your health."
(g)
Product labeling for cannabis mix identified as compliant cannabis product
under
RCW
69.50.375(4) and chapter
246-70 WAC may include:
(i) A structure or
function claim describing the intended role of the product to maintain the
structure or any function of the body; or
(ii) Characterization of the documented
mechanism by which the product acts to maintain such structure or function,
provided that the claim is truthful and not misleading.
(iii) Any statement made under this
subsection may not claim to diagnose, mitigate, treat, cure, or prevent any
disease.
(h) Where there
is one statement made under (g) of this subsection, or there is a warning
describing the psychoactive effects of the cannabis product, provided it is not
false or misleading, the disclaimer must state, "This statement has not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(i) Where there is more than one statement
made under (g) of this subsection, or there is a warning describing the
psychoactive effects of the cannabis product, provided they are not false or
misleading, the disclaimer must state, "These statements have not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(7)
Cannabis topicals. The
following standards apply to all packaging and labeling of cannabis topicals:
(a) Containers or packaging containing a
cannabis topical must protect the product from contamination. Containers or
packaging must not impart any toxic or harmful substance to the cannabis
topical.
(b) Cannabis topicals must
not be labeled as organic unless permitted by the U.S. Department of
Agriculture consistent with the Organic Foods Production Act.
(c) Cannabis topicals must comply with the
version of NIST Handbook 130, Uniform Packaging and Labeling regulation adopted
in chapter 16-662 WAC.
(d) Labels
for cannabis topicals must clearly and visibly provide all of the following
information:
(i) The business or trade name
and the nine digit Washington state unified business identifier (UBI) number of
the licensees that produced and processed the cannabis or cannabis
products;
(ii) The lot number of
the product (the unique identifier number generated by the board's traceability
system). This must be the same number that appears on the transport
manifest;
(iii) The label must
prominently display the net weight in ounces and grams or volume as applicable,
and may not exceed serving and transaction limits as described in WAC
314-55-095;
(iv) Total THC (delta-9-tetrahydrocannabinol)
meaning the concentration of THC and THCA, total CBD (cannabidiol) meaning the
concentration of CBDA and CBD, using the formulas referenced in WAC
314-55-102;
(v) Medically and scientifically accurate and
reliable information about the health and safety risks posed by cannabis use;
and
(vi) A list of all ingredients
in descending order of predominance by weight or volume as
applicable.
(e) Labels
for cannabis topicals may not contain any statement, depiction, or illustration
that:
(i) Is false or misleading, consistent
with guidance provided in
21 C.F.R. Sec.
101.18(a);
(ii) Promotes over consumption;
(iii) Represents the use of cannabis has
curative or therapeutic effects;
(iv) Depicts a person under the age of 21
consuming cannabis, or is especially appealing to persons under 21 years of age
as defined in subsection (1)(c) of this section.
(f) The following warning statements must be
included on all labels for all cannabis topicals. The following warning
statements must be legible, unobscured, and visible to the consumer:
(i) "Unlawful outside Washington
State;"
(ii) The cannabis universal
symbol as provided in WAC
314-55-106;
and
(iii) "DO NOT EAT"
in bold, capital letters.
(g) Product labeling for cannabis topicals
identified as compliant cannabis product under
RCW
69.50.375(4) and chapter
246-70 WAC may include:
(i) A structure or
function claim describing the intended role of the product to maintain the
structure or any function of the body; or
(ii) Characterization of the documented
mechanism by which the product acts to maintain such structure or function,
provided that the claim is truthful and not misleading.
(iii) Any statement made under this
subsection may not claim to diagnose, mitigate, treat, cure, or prevent any
disease.
(h) Where there
is one statement made under (g) of this subsection, or there is a warning
describing the psychoactive effects of the cannabis product, provided it is not
false or misleading, the disclaimer must state, "This statement has not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(i) Where there is more than one statement
made under (g) of this subsection, or there is a warning describing the
psychoactive effects of the cannabis product, provided they are not false or
misleading, the disclaimer must state, "These statements have not been
evaluated by the State of Washington. This product is not intended to diagnose,
treat, cure, or prevent any disease."
(8)
Optional label information.
Optional label information includes the following: Harvest date, "best by"
date, and manufactured dates.
(9)
Accompanying materials. Accompanying materials must be provided
with a cannabis product or made available to the consumer purchasing cannabis
products.
A producer or processor must provide the following
product-specific information, for as long as the product is for sale, through
an internet link, web address, or QR code on the product label as
follows:
(a) A statement disclosing
all pesticides applied to the cannabis plants and growing medium during
production of the useable cannabis or the base cannabis used to create the
concentrate or the extract added to infused products;
(b) A list disclosing all of the chemicals,
compounds, additives, thickening agents, terpenes, or other substances added to
any cannabis concentrate during or after production.
(10)
Upon request materials. A
consumer may request the name of the certified lab and quality assurance test
results for any cannabis or cannabis product. A retailer must provide the
information upon request.
Statutory Authority:
RCW
69.50.325,
69.50.331,
69.50.342,
69.50.345. WSR 13-21-104,
§ 314-55-105, filed 10/21/13, effective 11/21/13. WSR 13-21-003,
§ 314-55-105, filed 10/3/2013, effective
11/3/2013